An Investigation Into the Efficacy of Provodine Topical Cream as Compared to 10% Benzoyl Peroxide Wash for the Treatment of Hidradenitis Suppurativa.

• Status: Unknown status
• Trial end date: 2013-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to compare the efficacy of Provodine™ topical cream to 10% benzoyl peroxide topical body wash for the treatment of early stage hidradenitis suppurativa.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Henry Ford Health System
• Collaborator: Microdermis Corporation
• Treatments: Benzoyl Peroxide

Criteria

Inclusion Criteria:

• For inclusion, the subject must:

1. Be at least 13 years old.

2. Be otherwise healthy.

3. Have a diagnosis of HS.

4. Patients must have Hurley stage I or Stage II HS

5. Be able to understand the requirements of the study, the risks involved, and be able to sign the informed consent form.

6. Agree to follow and undergo all study-related procedures.

7. If applicable, minors must have permission of legal guardian for participation in the study.

Exclusion Criteria:

• Subjects who meet the following criteria will be excluded:

1. Patients with HS Hurley stage III will be excluded from participation in the study

2. Patients who are pregnant or breast feeding will not be able to take part in the study due to the unknown effects of the topical medications.

3. Concomitant use of systemic or other topical treatments for HS not involved in current study. For cohort I, no washout period for systemic and/or topical medications will be required. For Cohort II, there will be a 14 day minimum washout period for systemic and topical treatments for HS.

4. Any reason the investigator feels the patient should not participate in the study.

5. If a patient misses ≥ 2 consecutive study visits, the patient will be excluded from further participation in this trial.

6. History of allergy to iodine or benzoyl peroxide.